Reza Zadno - Sep 14, 2021 Form 3 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
President, CEO, Director
Signature
/s/ Alaleh Nouri, Attorney-in-Fact for Reza Zadno, MD
Stock symbol
PRCT
Transactions as of
Sep 14, 2021
Transactions value $
$0
Form type
3
Date filed
9/14/2021, 07:16 PM
Next filing
Sep 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PRCT Common Stock 52.6K Sep 14, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PRCT Series F Convertible Preferred Stock Sep 14, 2021 Common Stock 3.39K Direct F1
holding PRCT Stock Option (Right to Buy) Sep 14, 2021 Common Stock 1.32M $4.37 Direct F2
holding PRCT Stock Option (Right to Buy) Sep 14, 2021 Common Stock 254K $5.18 Direct F3
holding PRCT Stock Option (Right to Buy) Sep 14, 2021 Common Stock 173K $7.27 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock , Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock (collectively, the "Preferred Stock") will convert automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date.
F2 The Stock option was granted on February 20, 2020 and vests 25% on the anniversary of the vesting commencement date of February 1, 2020 and the remaining shares vest on each monthly anniversary over a 3 year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.
F3 The Stock option was granted on August 10, 2020 and vests 12.5% on the 6 month anniversary of the vesting commencement date of August 1, 2020 and the remaining shares vest on each monthly anniversary over a 3.5 year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.
F4 The Stock option was granted on June 22, 2021 and vests 25% on the sixth month anniversary of the vesting commencement date of June 22, 2021 and the reaming shares vest on each monthly anniversary over a 4 year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney